ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $330,000 | -61.4% | 15,400 | -62.2% | 0.01% | -50.0% |
| Q1 2017 | $856,000 | -34.0% | 40,741 | -16.9% | 0.01% | -45.5% |
| Q1 2016 | $1,297,000 | -66.2% | 49,036 | -45.4% | 0.02% | -26.7% |
| Q4 2015 | $3,840,000 | -41.8% | 89,748 | -54.7% | 0.03% | -67.0% |
| Q1 2015 | $6,595,000 | +748.8% | 198,138 | +764.6% | 0.09% | +810.0% |
| Q3 2014 | $777,000 | +160.7% | 22,918 | +159.7% | 0.01% | +150.0% |
| Q2 2014 | $298,000 | -51.1% | 8,824 | -57.7% | 0.00% | -42.9% |
| Q4 2013 | $609,000 | -78.0% | 20,841 | -74.3% | 0.01% | -75.9% |
| Q3 2013 | $2,770,000 | +793.5% | 81,003 | +761.1% | 0.03% | +866.7% |
| Q2 2013 | $310,000 | – | 9,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |